How France is Pioneering Digital Health Reimbursement
France has the most developed approach to reimbursement for digital health in Europe—an ongoing priority recognized in the “Plan France 2030.”
📌 Reimbursement Pathways in France
Several pathways exist for digital health reimbursement, each tailored to different technologies and needs:
- 🔹 Temporary Reimbursement for Digital Therapeutics (DTx) & Telemonitoring during evidence development, before transitioning to permanent reimbursement (PECAN).
- 🔹 Remote Monitoring pathways:
- ✅ Pre-defined category (generic) solutions.
- ✅ New indications requiring approval (LATM).
- 🔹 Permanent Reimbursement for DTx under LPPR (Liste des Produits et Prestations Remboursables).
Each pathway has unique characteristics depending on the type of technology and its intended use.
🚀 Plan France 2030: A Digital Health Powerhouse
The French government has committed €718.4 million through Plan France 2030 to accelerate digital health adoption. This investment is fostering a thriving ecosystem that supports projects shifting healthcare towards more preventive and personalized solutions.
These efforts are transforming France into a digital health eldorado, attracting innovators and investors alike. From AI-powered diagnostic tools to patient-centric mobile applications, the French digital health landscape is evolving rapidly.
🔬 Want to Learn More About France’s Digital Health Revolution?
Join our upcoming webinar on March 20th, where we'll dive deep into how you can leverage these pathways for your technology.
👉 Register Now